Lazaridis Lazaros-Dimitrios, Rizos Evripidis, Bounou Lamprini, Theodorou-Kanakari Anna, Kalousios Sotirios, Mavroeidi Electra-Antonia, Roma Maria, Chatzidakis Alexandros, Vlachonicolou Georgia, Miltiadou Konstantinos, Gkolfakis Paraskevas, Tziatzios Georgios, Triantafyllou Konstantinos
Hepatogastroenterology Unit, Second Department of Internal Propaedeutic Medicine-, Medical School, National and Kapodistrian University of Athens, "Attikon" University General Hospital, Athens, Greece.
Ann Gastroenterol. 2021 Nov-Dec;34(6):781-787. doi: 10.20524/aog.2021.0654. Epub 2021 Jul 2.
Misuse of proton pump inhibitors (PPIs) is an alarming issue for patients and healthcare systems.
We conducted a 3-phase interventional, prospective study in a Greek university hospital. During Phase I, we collected data from patients' records to evaluate the appropriate use of PPIs. During Phase II, educational seminars about the proper use of PPIs were offered to the medical staff. In Phase III we collected data from the records of patients admitted to the hospital department with the highest rate of inappropriate PPI administration during Phase I, to evaluate the efficacy of the intervention. Inappropriate use was defined as either PPI administration without indication, or lack of use despite adequate indication. Appropriateness of PPI use was measured at admission, during hospitalization and at discharge.
The rate of inappropriate PPI use was higher (51.7% and 48.6%) during hospitalization than at admission (34.9% and 21.9%), but at discharge was similar to pre-hospitalization levels (26.9% and 23.6%), in Phases I and III, respectively. At discharge during Phase I, the inappropriate use of PPIs was significantly higher (odds ratio 3.79, 95% confidence interval 1.98-7.19) for internal medicine patients than for surgical patients. The educational intervention failed to reduce the inappropriate use of PPIs during hospitalization (51.7% vs. 48.6%, P=0.478) or at discharge (26.9% vs. 23.6%, P=0.391) in the internal medicine patients.
The rate of inappropriate PPI use is almost double during hospitalization compared to the rates at admission and at discharge. Implementation of an educational intervention failed to reduce the inappropriate use of PPIs in internal medicine patients.
质子泵抑制剂(PPI)的滥用对患者和医疗系统而言是一个令人担忧的问题。
我们在一家希腊大学医院开展了一项为期3个阶段的干预性前瞻性研究。在第一阶段,我们从患者记录中收集数据,以评估PPI的合理使用情况。在第二阶段,为医务人员举办了关于PPI正确使用的教育研讨会。在第三阶段,我们从第一阶段PPI使用不当率最高的医院科室收治的患者记录中收集数据,以评估干预措施的效果。不当使用被定义为无指征使用PPI,或虽有充分指征但未使用。在入院时、住院期间和出院时评估PPI使用的合理性。
在第一阶段和第三阶段,住院期间PPI使用不当率(分别为51.7%和48.6%)高于入院时(分别为34.9%和21.9%),但出院时与住院前水平相似(分别为26.9%和23.6%)。在第一阶段出院时,内科患者PPI使用不当率显著高于外科患者(比值比3.79,95%置信区间1.98 - 7.19)。教育干预未能降低内科患者住院期间(51.7%对48.6%,P = 0.478)或出院时(26.9%对23.6%,P = 0.391)PPI的不当使用率。
与入院时和出院时相比,住院期间PPI使用不当率几乎高出一倍。实施教育干预未能降低内科患者PPI的不当使用率。